TyG-BMI is a stronger predictor of CRC risk than the TyG index, showing a linear association with CRC incidence. Subgroup analysis reveals a significant link between TyG-BMI and CRC risk ...

Opdualag – which combines the PD-1 inhibitor nivolumab in BMS' blockbuster cancer drug Opdivo with LAG-3 inhibitor relatlimab – was unable to improve on Opdivo alone in the RELATIVITY-098 ...

The EMA's human medicines committee has said it does not recommend approval of Eli Lilly's anti-amyloid Alzheimer's disease treatment Kisunla, saying its modest benefits don't outweigh its risks.

During a live event, Guru P. Sonpavde, MD discussed improvements to survival with cabozantinib plus nivolumab in metastatic renal cell carcinoma. A 65-year-old man presented with back pain for past 6 ...

The study included US patients from the TriNetX database who had solid tumor malignancies and received durvalumab, nivolumab, ipilimumab, or pembrolizumab between 2012 and 2024. The researchers ...

By utilizing ipilimumab, an immunotherapy drug already used for cancer treatment, the researchers were able to block CTLA4 in experimental mice. This action effectively lifted the inhibition on ...

Why Choose Our Missouri Personal Injury Law Firm? Since 1979, our Missouri personal injury law firm has helped thousands of families secure compensation after experiencing physical, emotional, and ...

Why Choose Our Texas Personal Injury Law Firm? Since 1979, our Texas personal injury law firm has helped thousands of families secure compensation after experiencing physical, emotional, and financial ...